These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 26166143)
21. Acute renal failure induced by an angiotensin II receptor antagonist in a 14-year-old boy with reflux nephropathy. Fujinaga S; Kaneko K; Ohtomo Y; Yamashiro Y Pediatr Nephrol; 2006 Apr; 21(4):601-2. PubMed ID: 16534606 [No Abstract] [Full Text] [Related]
27. Adverse events in HEAAL: when to hold and when to fold. Pitt B Eur J Heart Fail; 2012 Dec; 14(12):1319-21. PubMed ID: 23159580 [No Abstract] [Full Text] [Related]
28. Efficacy and safety of the angiotensin II receptor blocker losartan for hypertrophic cardiomyopathy: the INHERIT randomised, double-blind, placebo-controlled trial. Axelsson A; Iversen K; Vejlstrup N; Ho C; Norsk J; Langhoff L; Ahtarovski K; Corell P; Havndrup O; Jensen M; Bundgaard H Lancet Diabetes Endocrinol; 2015 Feb; 3(2):123-31. PubMed ID: 25533774 [TBL] [Abstract][Full Text] [Related]
29. Sprue-like enteropathy associated with olmesartan - broadening the differential diagnosis of enteropathy. Rubio-Tapia A Aliment Pharmacol Ther; 2014 Dec; 40(11-12):1362-3. PubMed ID: 25376200 [No Abstract] [Full Text] [Related]
30. Intraoperative anaphylaxis due to beta-lactams in a hypertensive patient on angiotensin ii receptor antagonists and beta-blockers. Navarro Suay R; de Tena Gómez MD; García Aroca MÁ; López Soberón E Rev Esp Anestesiol Reanim; 2015 Feb; 62(2):113-4. PubMed ID: 25048998 [No Abstract] [Full Text] [Related]
31. High-dose versus low-dose losartan in patients with heart failure. Kang SM; Oh J; Hong N Lancet; 2010 Mar; 375(9720):1079; author reply 1079-80. PubMed ID: 20346808 [No Abstract] [Full Text] [Related]
32. Use of olmesartan for ≥ 1 year was associated with hospitalization for intestinal malabsorption. Talley NJ Ann Intern Med; 2015 Dec; 163(12):JC13. PubMed ID: 26666803 [No Abstract] [Full Text] [Related]
33. Letter: sprue-like enteropathy associated with angiotensin II receptor blockers other than olmesartan. Zanelli M; Negro A; Santi R; Bisagni A; Ragazzi M; Ascani S; De Marco L Aliment Pharmacol Ther; 2017 Aug; 46(4):471-473. PubMed ID: 28707802 [No Abstract] [Full Text] [Related]
34. Letter: sprue-like enteropathy associated with angiotensin II receptor blockers other than olmesartan-authors'reply. Marthey L; Carbonnel F Aliment Pharmacol Ther; 2017 Aug; 46(4):473-474. PubMed ID: 28707797 [No Abstract] [Full Text] [Related]
35. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option. Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075 [TBL] [Abstract][Full Text] [Related]
38. Losartan and hypertensive children. Another option for a small number of children. Prescrire Int; 2010 Aug; 19(108):160. PubMed ID: 20939445 [No Abstract] [Full Text] [Related]
39. Efficacy and safety of angiotensin II receptor blockade in elderly patients with diabetes. Winkelmayer WC; Zhang Z; Shahinfar S; Cooper ME; Avorn J; Brenner BM Diabetes Care; 2006 Oct; 29(10):2210-7. PubMed ID: 17003295 [TBL] [Abstract][Full Text] [Related]